Literature DB >> 20209707

Efficacy and safety of procedural sedation and analgesia by paediatric intensivist in paediatric oncology unit.

Anwarul Haque1, Zahra Fadoo.   

Abstract

Children with cancer especially acute leukaemia undergo multiple painful procedures like bone marrow biopsy (BM) and lumber puncture (LP) for intrathecal chemotherapy during their first year of treatment. The purpose of this study is to report safety and efficacy of Procedural Sedation and Analgesia (PSA) by paediatric intensivist for oncology procedures in controlled setting in paediatric oncology unit. During 20 months, 124 children received PSA for 499 procedures. 324 LP alone, 175 BM alone and 40 combined LP and BM were done. The most common diagnosis was acute leukaemia and lymphoma. All procedures were in compliance with American Society of Anaesthesiology guidelines. A small-dose of ketamine and intermittent doses of propofol was administered intravenously until needed. No procedure was aborted due to sedation. All patients tolerated the procedure well without any major adverse events. There were few transient respiratory adverse events which resolved with minor interventions. PSA for children undergoing oncology procedures, can safely and effectively be provided by paediatric intensivist in controlled setting by using a standardized sedation protocol outside the operating room.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20209707

Source DB:  PubMed          Journal:  J Pak Med Assoc        ISSN: 0030-9982            Impact factor:   0.781


  2 in total

1.  Safety and Efficacy of Procedural Sedation and Analgesia in Pediatric Oncology Patients.

Authors:  Saba Laila Aslam; Anwar Haque; Muhammad Tariq Jamil; Madiha Ariff; Saad Nasir
Journal:  Cureus       Date:  2020-03-28

2.  Procedural pediatric sedation by nurses: available, competent, and safe.

Authors:  Laetiscia Lavoie; Catherine Vezina; Emilie Paul-Savoie; Claude Cyr; Sylvie Lafrenaye
Journal:  Int J Pediatr       Date:  2012-04-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.